Reducing the burden of glandular carcinomas of the uterine cervixHERZOG, Thomas J; MONK, Bradley J.American journal of obstetrics and gynecology. 2007, Vol 197, Num 6, pp 566-571, issn 0002-9378, 6 p.Article

Recent Achievements and Future Developments in Advanced and Recurrent Cervical Cancer : Trials of the Gynecologic Oncology Group : Gynecologic cancer updateTEWARI, Krishnansu S; MONK, Bradley J.Seminars in oncology. 2009, Vol 36, Num 2, pp 170-180, issn 0093-7754, 11 p.Article

Cervical neoplasia in pregnancy. Part 2: current treatment of invasive diseaseHUNTER, Mark I; TEWARI, Krishnansu; MONK, Bradley J et al.American journal of obstetrics and gynecology. 2008, Vol 199, Num 1, pp 10-18, issn 0002-9378, 9 p.Article

New developments in the treatment of invasive cervical cancerIM, Samuel S; MONK, Bradley J.Obstetrics and gynecology clinics of North America. 2002, Vol 29, Num 4, issn 0889-8545, vi, 659-672 [15 p.]Article

Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive diseaseHUNTER, Mark I; MONK, Bradley J; TEWARI, Krishnansu S et al.American journal of obstetrics and gynecology. 2008, Vol 199, Num 1, pp 3-9, issn 0002-9378, 7 p.Article

Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer : Advances in Epithelial Ovarian Cancer TherapyMONK, Bradley J; DALTON, Heather; BENJAMIN, Ivor et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 25, pp 3754-3769, issn 1381-6128, 16 p.Article

Green tea catechins for treatment of external genital wartsMELTZER, Sara M; MONK, Bradley J; TEWARI, Krishnansu S et al.American journal of obstetrics and gynecology. 2009, Vol 200, Num 3, pp 233-234, issn 0002-9378, 2 p.Article

Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma : A gynecologic oncology group studyWENZEL, Lari; HUANG, Helen Q; MONK, Bradley J et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5605-5612, issn 0732-183X, 8 p.Article

Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasionIM, Samuel S; WILCZYNSKI, Sharon P; BURGER, Robert A et al.Clinical cancer research. 2003, Vol 9, Num 11, pp 4145-4150, issn 1078-0432, 6 p.Article

A clinical pathway for postoperative management and early patient discharge : does it work in gynecologic oncology?CHASE, Dana M; LOPEZ, Sarah; NGUYEN, Christina et al.American journal of obstetrics and gynecology. 2008, Vol 199, Num 5, pp 541-542, issn 0002-9378, 2 p.Article

Phase ii study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: A Gynecologic oncology group studyMORRIS, Mitchell; BLESSING, John A; MONK, Bradley J et al.Journal of clinical oncology. 2004, Vol 22, Num 16, pp 3340-3344, issn 0732-183X, 5 p.Article

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix : A gynecologic oncology group studyMONK, Bradley J; HUANG, Helen Q; CELLA, David et al.Journal of clinical oncology. 2005, Vol 23, Num 21, pp 4617-4625, issn 0732-183X, 9 p.Article

Prognostic factors in neuroendocrine small cell cervical carcinoma:A multivariate analysisCHAN, John K; LOIZZI, Vera; BURGER, Robert A et al.Cancer. 2003, Vol 97, Num 3, pp 568-574, issn 0008-543X, 7 p.Article

Improved Survival with Bevacizumab in Advanced Cervical CancerTEWARI, Krishnansu S; SILL, Michael W; MICHAEL, Helen E et al.The New England journal of medicine. 2014, Vol 370, Num 8, pp 734-743, issn 0028-4793, 10 p.Article

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group StudyDE GEEST, Koen; BLESSING, John A; MORRIS, Robert T et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 149-153, issn 0732-183X, 5 p.Article

Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma : A gynecologic oncology group studyHOMESLEY, Howard D; FILIACI, Virginia; MARKMAN, Maurie et al.Journal of clinical oncology. 2007, Vol 25, Num 5, pp 526-531, issn 0732-183X, 6 p.Article

Development of an in vitro chemo-radiation response assay for cervical carcinomaMONK, Bradley J; BURGER, Robert A; PARKER, Ricardo et al.Gynecologic oncology (Print). 2002, Vol 87, Num 2, pp 193-199, issn 0090-8258, 7 p.Article

Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix : A Gynecologic Oncology Group StudyMONK, Bradley J; SILL, Michael W; BURGER, Robert A et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1069-1074, issn 0732-183X, 6 p.Article

Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat modelCHAN, John K; MONK, Bradley J; BERNS, Michael et al.Gynecologic oncology (Print). 2002, Vol 87, Num 1, pp 64-70, issn 0090-8258Article

Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiationMONK, Bradley J; TEWARI, Krishnansu S; PUTHAWALA, Ajmel A et al.International journal of radiation oncology, biology, physics. 2002, Vol 52, Num 3, pp 806-815, issn 0360-3016Article

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised womenCHAN, John K; LIN, Yvonne G; MONK, Bradley J et al.Obstetrics and gynecology (New York. 1953). 2001, Vol 97, Num 5, pp 707-711, issn 0029-7844, 1Article

Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervixMCHALE, Michael T; LE, Thuan D; BURGER, Robert A et al.Obstetrics and gynecology (New York. 1953). 2001, Vol 98, Num 5, pp 726-731, issn 0029-7844, 1Article

Incorporation of Bevacizumab in the Primary Treatment of Ovarian CancerBURGER, Robert A; BRADY, Mark F; BOENTE, Matthew et al.The New England journal of medicine. 2011, Vol 365, Num 26, pp 2473-2483, issn 0028-4793, 11 p.Article

The Role of Antioxidants and Vitamin A in Ovarian Cancer : Results From the Women's Health InitiativeTHOMSON, Cynthia A; NEUHOUSER, Marian L; SHIKANY, James M et al.Nutrition and cancer. 2008, Vol 60, Num 6, pp 710-719, issn 0163-5581, 10 p.Article

Pretreatment CA-125 and risk of relapse in advanced ovarian cancerMARKMAN, Maurie; LIU, P. Y; ROTHENBERG, Mace L et al.Journal of clinical oncology. 2006, Vol 24, Num 9, pp 1454-1458, issn 0732-183X, 5 p.Article